For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

The incidence of early-onset colorectal cancer has been increasing worldwide, a trend that has coincided with growing intake ...

Increased stiffness in the colon may encourage the development and progression of early-onset colorectal cancer, a new study ...

A research team at Queen’s University is seeking to understand how bowel cancer develops resistance to treatments including ...

Innovent Biologics has received China’s NMPA approval for the NDA for Tabosun, a CTLA-4 monoclonal antibody for colon cancer.